Facilitating European Clinical Research

ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe
to facilitate multinational clinical research. We provide sponsors and investigators with advice,
management services and tools to overcome hurdles to multinational trials and enhance collaboration.

Our Work

We provide our 12 member and observer countries with diverse trial support services
and contribute to 'infrastructure development' projects with additional European and international partners.

ECRIN in Numbers

Member & Observer Countries

Million citizens represented

Trials in ECRIN portfolio

Average # of countries per trial

Events

Date:

The EOSC-Life project will be organising several thematic workshops, the first of which will be on pseudo-anonymisation of health data. This event will be held with project partners in Paris from 22 to 22 January 2020.  

Date:

The PERMIT (PERsonalised MedicIne Trials) project will hold its kick-off meeting on 24 January 2020 in Paris. 

The Horizon 2020-funded project will establish recommendations to ensure the robustness of personalised medicine trials. 

PERMIT has received funding from Horizon 2020 under grant agreement number 874825.

Date:

The final CORBEL meeting will take place on 2 March 2020 in Florence, Italy. The consortium will present their solutions for harmonising user access to the European life science research infrastructures (RIs), comprising topics such as access, data or quality management, training, ELSI and innovation support. Presentations by scientists from the biological and medical user communities will illustrate how concerted access to multiple RIs advanced their projects, thus demonstrating the benefit of CORBEL for European life science research.

The one-day meeting will be open to European scientists from the biological and medical field, potential users of the CORBEL common services as well as other stakeholders generally interested in CORBEL and the European life science RIs.

For registration information, please click here